Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study

• Main Authors: Bong-Joon Kim (Author), Kyoung-Im Cho (Author), Hyuck Moon Kwon (Author), Seung-Min Choi (Author), Chang-Hwan Yoon (Author), Sang Wook Lim (Author), Seung-Jae Joo (Author), Nam Ho Lee (Author), Sang-Yup Lim (Author), Seong-Hoon Lim (Author), Hyo-Soo Kim (Author)
• Format: Book
• Published: BMC, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background This study evaluated the circadian efficacy of a telmisartan 40 mg/S-amlodipine 2.5 mg fixed-dose combination (Telmisartan40/S-Amlodipine2.5) compared to telmisartan 80 mg (Telmisartan80) in patients with essential hypertension who did not respond to 2-4 weeks' treatment wit...